Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

15.30
-0.2000-1.29%
Pre-market: 15.22-0.0800-0.52%07:08 EDT
Volume:1.70M
Turnover:25.96M
Market Cap:1.44B
PE:-4.85
High:15.52
Open:15.36
Low:14.90
Close:15.50
52wk High:16.15
52wk Low:1.50
Shares:94.22M
Float Shares:77.49M
Volume Ratio:0.73
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1550
EPS(LYR):-3.3828
ROE:-134.29%
ROA:-51.30%
PB:13.65
PE(LYR):-4.52

Loading ...

Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process

TIPRANKS
·
Aug 28

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop

TIPRANKS
·
Aug 22

Replimune Grants CCO Michelle DiNapoli Options for 150,000 Shares at $15.58, Plus 100,000 RSUs

Reuters
·
Aug 20

Press Release: Replimune Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Aug 20

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop

TIPRANKS
·
Aug 19

Jefferies Remains a Buy on Replimune Group (REPL)

TIPRANKS
·
Aug 17

Replimune files automatic mixed securities shelf

TIPRANKS
·
Aug 16

Replimune Group, Inc. Files for Mixed Shelf; Size not Disclosed - SEC Filing

THOMSON REUTERS
·
Aug 15

Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop

TIPRANKS
·
Aug 15

Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update

Reuters
·
Aug 14

Replimune Q1 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 14

Earnings Flash (REPL) Replimune Posts Fiscal Q1 Net Loss $0.72 a Share, vs. FactSet Est of $0.66 Loss

MT Newswires Live
·
Aug 14

Replimune Group Q1 EPS $(0.72) Beats $(0.73) Estimate

Benzinga Earnings
·
Aug 14

Replimune FY27 Q1 Net Loss Narrows to $69.8 Million; R&D Expenses Fall to $49.3 Million

Reuters
·
Aug 14

Replimune Group Q1 EPS USD -0.72

THOMSON REUTERS
·
Aug 14

Baker Bros. Advisors Membeli Saham Replimune Senilai USD 33,01 Juta

Reuters
·
Aug 12

Replimune Amends Filing to Correct Pre-Funded Warrant Beneficial Ownership Limits

Reuters
·
Aug 11

Replimune Shares Rise After Pricing of Offering

Dow Jones
·
Aug 11

Replimune Jumps After $150 Mln Equity Offering for Skin Cancer Drug

Reuters
·
Aug 11